Search for: ""Wyeth v. Levine" OR "555 U.S. 555"" Results 21 - 40 of 74
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2013, 5:00 am by Bexis
  That’s a long way from the sweeping presumption language in Wyeth v. [read post]
7 Jan 2015, 6:54 am
Levine, 555 U.S. 555 (2009), has no bearing because it wasn’t a design claim at all. [read post]
17 Nov 2015, 5:00 am
Not quite two years ago, we posted about how, under Wyeth v. [read post]
27 Jun 2011, 5:47 am by Lisa Baird
Levine, 555 U.S. 555 (2009), which rejected preemption for failure to warn claims against brand name manufacturers just two years ago. [read post]
31 Oct 2013, 5:00 am
Levine, 555 U.S. 555 (2009)) innovator drug processes. [read post]
22 Mar 2016, 7:48 am
Levine, 555 U.S. 555 (2009), defendant has to demonstrate the conflict between state and federal law by “clear evidence. [read post]
5 Feb 2013, 11:32 am by Michelle Yeary
Levine, 555 U.S. 555 (2009), doesn’t leave brand defendants a lot to work with, there are still arguments to be made. [read post]
6 Nov 2014, 5:00 am
Levine, 555 U.S. 555 (2009)), invoked greater ire from us than the atrocity in State ex rel. [read post]
7 Jun 2012, 2:40 pm by Bexis
Levine, 555 U.S. 555 (2009), before being consigned to 4-4 limbo in PLIVA, Inc. [read post]
30 Mar 2022, 7:01 pm by Sean Wajert
Levine, 555 U.S. 555 (2009), particularly with regard to the need in a warnings context that there should be clear evidence that the FDA would have rejected the plaintiff’s proposed alternative label. [read post]